ACLS

Post-Resuscitation Phase: ROSC Management Step by Step

After successful resuscitation, the critical post-ROSC phase begins: targeted temperature management, hemodynamics, ventilation, coronary angiography indications, and neuroprognostication. This article explains the AHA Post-Cardiac Arrest Algorithm for continued clinical care.

Dr. med. univ. Daniel Pehböck, DESA

Author: Dr. med. univ. Daniel Pehböck, DESA

Specialist in Anesthesiology and Intensive Care Medicine, AHA-certified ACLS/PALS Instructor, Course Director Simulation Tirol

Reading time approx. 8 min

Return of Spontaneous Circulation (ROSC) does not mark the end of a resuscitation but rather the beginning of one of the most critical phases in emergency medicine. Mortality after initially successful resuscitation remains high – a significant proportion of patients die in the first hours and days after ROSC from the consequences of Post-Cardiac Arrest Syndrome. This syndrome encompasses a complex pathophysiology consisting of global ischemia-reperfusion injury, the persistent cause of cardiac arrest, hypoxic-ischemic encephalopathy, and myocardial dysfunction. A structured, algorithm-based approach to continued care in the post-resuscitation phase is therefore crucial for neurological outcome and survival. The AHA Post-Cardiac Arrest Algorithm provides you with a clear, stepwise framework for action.

Understanding Post-Cardiac Arrest Syndrome

To grasp the therapeutic goals of the post-ROSC phase, it is worth taking a closer look at the underlying pathophysiology. Post-Cardiac Arrest Syndrome can be divided into four interrelated components:

  • Hypoxic-ischemic brain injury: The brain's vulnerability to ischemia makes it the primary target organ. Reperfusion injury, excitotoxicity, free radicals, and apoptosis lead to progressive neuronal death that extends over hours to days.
  • Myocardial dysfunction: A global cardiac stunning response with reduced ejection fraction occurs regularly after prolonged cardiac arrest. This dysfunction is often reversible but requires aggressive hemodynamic management.
  • Systemic ischemia-reperfusion response: The generalized activation of inflammatory cascades resembles sepsis (vasoplegia, capillary leak, endothelial damage) and leads to multi-organ dysfunction.
  • Persistent precipitating pathology: The cause of the cardiac arrest – whether an acute myocardial infarction, pulmonary embolism, or metabolic derangement – persists and must be identified and treated.

Understanding these four pillars is the foundation for every therapeutic decision after ROSC.

Immediate Measures After ROSC: The First Minutes

Immediately after restoration of a stable circulation, you should proceed systematically. The first minutes determine the further clinical course.

Airway Management and Ventilation

  • Ensure endotracheal intubation if not already performed. Verify correct tube placement using capnography – capnography remains the standard monitoring tool even after ROSC.
  • Target SpO₂: 92–98%. Hyperoxia is harmful and increases oxidative stress during the reperfusion phase. Reduce FiO₂ as quickly as possible to avoid values above 98%.
  • Target PaCO₂: 35–45 mmHg (normocapnia). Both hypocapnia (cerebral vasoconstriction, worsening of cerebral perfusion) and hypercapnia (increase in intracranial pressure) must be avoided.
  • Tidal volume: 6–8 ml/kg ideal body weight with lung-protective ventilation. Use a respiratory rate of 10/min as a starting point, then titrate based on arterial blood gas analysis.

Hemodynamic Management

Myocardial dysfunction after cardiac arrest requires proactive circulatory management:

  • Target: Systolic blood pressure ≥ 90 mmHg or mean arterial pressure (MAP) ≥ 65 mmHg. Many experts recommend a MAP ≥ 80 mmHg to optimize cerebral perfusion, with growing evidence supporting this higher target.
  • Fluid therapy: Initial bolus of crystalloid solutions (e.g., Ringer's lactate, 250–500 ml) if volume depletion is suspected. Use caution in cardiogenic shock – excessive fluid administration can be deleterious.
  • Vasopressors and inotropes:
    • Norepinephrine as the first-line vasopressor (starting dose 0.1–0.5 µg/kg/min, titrate to MAP).
    • Dobutamine for pronounced myocardial dysfunction with low-output syndrome (2–20 µg/kg/min) in addition to norepinephrine.
    • Epinephrine as an alternative (0.1–0.5 µg/kg/min) when combined vasoconstrictive and inotropic effects are required.
  • Invasive monitoring: Establish arterial access as quickly as possible for continuous blood pressure monitoring and serial blood gas analyses. A central venous catheter is useful for vasopressor administration and CVP monitoring.

12-Lead ECG

A 12-lead ECG must be obtained as soon as possible after ROSC. Identification of ST-segment elevation or a new left bundle branch block has immediate therapeutic consequences – more on this in the coronary angiography section.

Targeted Temperature Management (TTM)

Targeted temperature management is one of the few interventions in the post-resuscitation phase that has been demonstrated to improve neurological outcome. The evidence base has evolved over the years, and recommendations have been adjusted accordingly.

Indication

  • All comatose patients after ROSC (i.e., absence of meaningful response to verbal commands) benefit from TTM, regardless of the initial rhythm (shockable vs. non-shockable) and regardless of the setting (in-hospital vs. out-of-hospital).

Target Temperature

  • The AHA guidelines recommend a constant temperature between 32 and 36°C for at least 24 hours.
  • Fever prevention is essential: Even after completion of the active cooling phase, body temperature should be maintained below 37.5°C for at least 72 hours after ROSC. Fever during this phase significantly worsens neurological outcome.

Practical Approach

  • Induction: Begin cooling as quickly as possible. Methods include intravenous infusion of cold crystalloid solutions (30 ml/kg, 4°C – Note: no longer recommended as first-line for induction due to hemodynamic instability), surface cooling systems (cooling blankets, ice packs), intravascular cooling catheters, or nasal evaporative cooling.
  • Maintenance: Temperature-feedback-controlled systems (intravascular or surface) are superior to invasive or manual methods in terms of temperature stability.
  • Rewarming: Controlled at a rate of 0.25–0.5°C per hour. Overly rapid rewarming can lead to rebound hyperthermia, electrolyte shifts, and hemodynamic instability.

Monitoring During TTM

  • Continuous core temperature measurement (esophageal, bladder, or via pulmonary artery catheter)
  • Frequent electrolyte monitoring (potassium, magnesium, phosphate – hypothermia causes intracellular potassium shifts)
  • Coagulation monitoring (hypothermia inhibits plasmatic coagulation)
  • Blood glucose monitoring (insulin resistance during hypothermia)

Coronary Angiography After Cardiac Arrest

Acute coronary syndrome is the most common cause of out-of-hospital cardiac arrest with a shockable rhythm. The question of timing of coronary angiography is highly clinically relevant.

Clear Indication for Immediate Catheterization

  • ST-elevation myocardial infarction (STEMI) on the post-ROSC ECG: Immediate coronary angiography with PCI, regardless of neurological status. Catheter intervention and TTM run in parallel.
  • Cardiogenic shock as the suspected cardiac cause of the cardiac arrest.

Extended Indications – When Does It Get Complex?

  • In patients without ST-segment elevation, the decision must be made on an individual basis. The current recommendation states that coronary angiography may be reasonable when there is a high suspicion of a coronary cause even without STEMI criteria – particularly with a shockable initial rhythm, hemodynamic instability, or no obvious non-cardiac trigger.
  • The decision should be made by a multidisciplinary team (cardiology, intensive care medicine, emergency medicine).

Cause Investigation: Identifying Reversible Triggers

In parallel with the measures described above, the cause of the cardiac arrest must be systematically evaluated. The well-known H's and T's provide a useful framework even after ROSC:

H's:

  • Hypovolemia → evaluate volume status, search for bleeding source
  • Hypoxia → ventilation parameters, chest X-ray
  • Hydrogen ions (acidosis) → arterial blood gas analysis
  • Hypo-/hyperkalemia → electrolytes, immediate correction if needed
  • Hypothermia → measure core temperature

T's:

  • Tension pneumothorax → clinical examination, thoracic ultrasound, decompression if needed
  • Tamponade (cardiac) → focused echocardiography (POCUS)
  • Toxins → history, toxicology screening
  • Thrombosis (coronary) → ECG, troponin, coronary angiography
  • Thrombosis (pulmonary) → CT angiography, echocardiography (right heart strain)

A focused echocardiography is part of the standard post-ROSC evaluation: It provides information on global and regional wall motion abnormalities, pericardial effusion, right heart strain, and volume status.

Neuroprognostication: When and How?

Prognostic assessment after cardiac arrest is among the most difficult decisions in intensive care medicine. The AHA algorithm explicitly emphasizes that early prognostication based on single parameters must be avoided.

Core Principles

  • Begin prognostication no earlier than 72 hours after ROSC or – if TTM was performed – no earlier than 72 hours after achieving normothermia.
  • Multimodal approach: No single test can reliably predict outcome. The recommendation is to use at least two different modalities:
    • Clinical neurological examination: Bilaterally absent pupillary response and absent corneal reflex ≥ 72 hours after ROSC (Note: rule out residual effects of sedatives and neuromuscular blocking agents!)
    • Electrophysiology: EEG (status epilepticus, burst-suppression, absent reactivity), somatosensory evoked potentials (SSEP – bilaterally absent N20 response)
    • Biomarkers: Neuron-specific enolase (NSE) – high values suggest an unfavorable prognosis, although cut-off values are laboratory-dependent and not absolute
    • Imaging: CT head (generalized cerebral edema, loss of gray-white matter differentiation) and MRI (diffusion-weighted sequences show the extent of ischemic injury)

Pitfalls

  • Sedatives and neuromuscular blocking agents can confound the clinical neurological assessment for days. Metabolism is slowed during hypothermia.
  • Myoclonus alone is not a reliable prognostic indicator. Status myoclonus can – rarely – also occur in patients with good outcomes (Lance-Adams syndrome).
  • Self-fulfilling prophecy: The greatest danger is that a premature pessimistic prognosis leads to early withdrawal of treatment, which in turn "confirms" the poor prognosis.

Intensive Care Management: The First 24–72 Hours

Beyond TTM and hemodynamics, there are additional important aspects of structured post-ROSC intensive care:

Blood Glucose Management

  • Target: 140–180 mg/dl (7.8–10.0 mmol/l). Hypoglycemia (< 70 mg/dl) must be strictly avoided as it aggravates neuronal damage. Overly aggressive insulin therapy targeting normoglycemia has shown no benefit in studies and increases the risk of hypoglycemia.

Seizure Management

  • Clinical and subclinical seizures occur in up to one-third of comatose patients after cardiac arrest.
  • Continuous EEG monitoring is recommended to detect non-convulsive seizures.
  • Treatment: Levetiracetam, valproate, or benzodiazepines depending on the clinical situation. Prophylactic anticonvulsive therapy is not routinely recommended.

Organ Protection

  • Lung protection: Continue lung-protective ventilation (tidal volume 6–8 ml/kg IBW, titrate PEEP, plateau pressure < 30 cmH₂O).
  • Renal function: Monitor urine output, avoid nephrotoxic substances, optimize volume status. Evaluate the need for renal replacement therapy early.
  • Infection prevention: Aspiration pneumonia is common. Obtain cultures but do not administer prophylactic antibiotics as routine.

The AHA Post-Cardiac Arrest Algorithm at a Glance

In summary, the algorithm follows a clear sequence:

  1. Confirm ROSC → pulse, blood pressure, capnography waveform
  2. Optimize airway management → SpO₂ 92–98%, PaCO₂ 35–45 mmHg, lung-protective ventilation
  3. Stabilize hemodynamics → MAP ≥ 65 mmHg (preferably ≥ 80 mmHg), vasopressors and inotropes as needed
  4. 12-lead ECG → STEMI? → immediate coronary angiography
  5. Initiate TTM → 32–36°C for ≥ 24 hours in all comatose patients
  6. Search for the cause → H's and T's, POCUS, laboratory tests, imaging
  7. Admission to a specialized intensive care unit → ideally a Cardiac Arrest Center
  8. Neuroprognostication → no earlier than 72 hours, multimodal, no single-parameter decisions
  9. Rehabilitation planning → initiate cognitive and physical rehabilitation early

Practical Training

The post-resuscitation phase requires an interplay of solid algorithm knowledge, hemodynamic monitoring, ventilation management, and interdisciplinary decision-making – all under time pressure and with incomplete information. In the ACLS course from Simulation Tirol, you train the complete Post-Cardiac Arrest Algorithm in realistic simulation scenarios, from the first minute after ROSC to the ICU handover. The AHA-certified courses give you the opportunity to practice critical decision points in a safe environment and prepare your team for real emergencies. All course details and dates can be found at simulationtirol.com.

Want to practice this hands-on?

In our ACLS-Kurs (Advanced Cardiac Life Support) you practice this topic hands-on with high-tech simulators and experienced instructors.

More Articles

In cooperation with

Netzwerk KindersimulationAmerican Heart Association · ERC Guidelines